SARS-CoV-2-targeting monoclonal antibody therapies: A complementary strategy to vaccination.
immunoprecise.substack.com
Vaccines are a cornerstone of the battle against COVID-19, caused by SARS-CoV-2 virus. However, some people cannot get vaccinated for safety reasons (e.g., allergies, contra-indications) or they may not have an adequate immune system (e.g., immunocompromised, pre-existing conditions). Also, even though vaccines against SARS-CoV-2 deliver high initial protection, they quickly wane over time, leading to breakthrough infections. In combination with the emergence of new variants this requires frequent booster campaigns, leading to compliance issues. In fact, many of the people who were initially vaccinated did not opt for a booster.
SARS-CoV-2-targeting monoclonal antibody therapies: A complementary strategy to vaccination.
SARS-CoV-2-targeting monoclonal antibody…
SARS-CoV-2-targeting monoclonal antibody therapies: A complementary strategy to vaccination.
Vaccines are a cornerstone of the battle against COVID-19, caused by SARS-CoV-2 virus. However, some people cannot get vaccinated for safety reasons (e.g., allergies, contra-indications) or they may not have an adequate immune system (e.g., immunocompromised, pre-existing conditions). Also, even though vaccines against SARS-CoV-2 deliver high initial protection, they quickly wane over time, leading to breakthrough infections. In combination with the emergence of new variants this requires frequent booster campaigns, leading to compliance issues. In fact, many of the people who were initially vaccinated did not opt for a booster.